iRepertoire was the first to develop and commercialize immune repertoire sequencing technology and products. iRepertoire uses immune repertoire sequencing technology to access the body’s immunological memory, or “logbook” of all past infection and disease. Sequencing the immune repertoire can yield insights into the nature of the body’s immune response to disease and infection. The future market for iRepertoire will be in clinical and research applications that require immune assessment such as drug treatment monitoring, identification of minimal residual disease (MRD), immune monitoring after stem cell transplantation, vaccine studies, and biomarker development. iRepertoire provides primer kits and amplification to sequencing services to examine the TCR and BCR immune diversity in both humans and mice. iRepertoire also offers access to its proprietary repertoire analysis tools with the purchase of its regent systems. iRepertoire’s reagent systems allow researchers to easily and inexpensively generate their own Next Generation Sequencing libraries in the convenience of their laboratory and analyze their data with the iRepertoire’s proprietary software pipeline at no additional cost.This year, iRepertoire has launched automated immune repertoire amplification and extraction on their sister company’s iC-processor (iCubate, Inc.). iRepertoire is proud to be a part of the non-profit initiative R10K, or Repertoire 10,000, with the HudsonAlpha Institute for Biotechnology, which aims to study the immune repertoire of 100 different diseases. The company has developed two key indices to describe the immune repertoire, i.e., the diversity index and the sharing index. These indices allow iRepertoire to identify disease specific signatures for diagnosis, prognosis, and treatment guidance.
View Top Employees from iRepertoire, Inc.Website | http://www.irepertoire.com |
Revenue | $5 million |
Funding | $150000 |
Employees | 28 (28 on RocketReach) |
Founded | 2009 |
Address | 800 Hudson Way Suite 2304, Huntsville, Alabama 35806, US |
Phone | (256) 327-0948 |
Fax | (256) 327-0976 |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Biotechnology, Healthcare, Science and Engineering, Health Care |
Web Rank | 8 Million |
Keywords | Tcr Sequencing, Clonality Of Natural Htvl2, Tcr Somatic Mutation, Irepertoire, Paired End Reads, Single Cell Bcr Sequencing |
Competitors | Adaptive Biotechnologies Corp., Biothera Pharmaceuticals, Inc., Kite Pharma, Metamark Genetics, NanoString Technologies, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular iRepertoire, Inc. employee's phone or email?
The iRepertoire, Inc. annual revenue was $5 million in 2024.
Jian Han is the Founder and Chairman of the board of iRepertoire, Inc..
28 people are employed at iRepertoire, Inc..
iRepertoire, Inc. is based in Huntsville, Alabama.
The NAICS codes for iRepertoire, Inc. are [541, 541713, 5417, 54171, 54].
The SIC codes for iRepertoire, Inc. are [873, 87].